• FirefoxInstall the new Firefox »
  •  Dow Down 0.47% Nasdaq Down 0.56%

    AbbVie Inc. (ABBV)

    -NYSE
    59.62 Down 0.84(1.39%) 4:02PM EST
    |After Hours : 59.50 Down 0.12 (0.20%) 5:54PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:60.46
    Open:60.35
    Bid:59.50 x 300
    Ask:59.90 x 23700
    1y Target Est:68.64
    Beta:1.66
    Earnings Date:Apr 23 - Apr 27 (Est.)
    Day's Range:59.44 - 60.45
    52wk Range:45.50 - 70.76
    Volume:7,388,012
    Avg Vol (3m):9,651,980
    Market Cap:95.03B
    P/E (ttm):54.20
    EPS (ttm):1.10
    Div & Yield:2.04 (3.40%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ABBVDown 1.39%95.03B
    MRKDown 0.41%165.58B
    NVSDown 1.01%237.61B
    PFEDown 0.60%211.81B

    Key Statistics

    Forward P/E (1 yr):11.92
    P/S (ttm):4.83
    Ex-Dividend Date:13-Apr-15

    Analysts

    Annual EPS Est (Dec-15) :4.39
    Quarterly EPS Est (Mar-15) :0.85
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):0.89

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback